Heart Failure Risk Prediction Datasetå¿ƒåŠ›è¡°ç«­é£é™©é¢„æµ‹æ•°æ®é›†
About this Dataset   å…³äºæœ¬æ•°æ®é›†
This dataset contains clinical data from 2,169 patients collected at Valley Medical Center (San Jose, California) during 2024. It is designed for developing machine learning models to predict heart failure risk based on 15 clinical features.è¯¥æ•°æ®é›†åŒ…å«2024å¹´åœ¨Valley Medical Center ï¼ˆSan Jose, Californiaï¼‰æ”¶é›†çš„2169åæ‚£è€…çš„ä¸´åºŠæ•°æ®ã€‚å®ƒæ—¨åœ¨å¼€å‘æœºå™¨å­¦ä¹ æ¨¡å‹ï¼Œæ ¹æ®15ä¸ªä¸´åºŠç‰¹å¾é¢„æµ‹å¿ƒåŠ›è¡°ç«­é£é™©ã€‚
Dataset Highlights   æ•°æ®é›†äº®ç‚¹

âœ… High Quality: 94.8/100 quality score, 0% missing dataâœ…é«˜è´¨é‡ï¼š94.8/100è´¨é‡åˆ†æ•°ï¼Œ0%ç¼ºå¤±æ•°æ®
âœ… Real Clinical Data: Collected from a county public hospital serving diverse communityâœ…çœŸå®ä¸´åºŠæ•°æ®ï¼šæ¥è‡ªæœåŠ¡äºä¸åŒç¤¾åŒºçš„å¿çº§å…¬ç«‹åŒ»é™¢
âœ… Well-Documented: Detailed measurement methods and quality control proceduresâœ…æ–‡ä»¶å®Œå¤‡ï¼šè¯¦ç»†çš„æµ‹é‡æ–¹æ³•å’Œè´¨é‡æ§åˆ¶ç¨‹åº
âœ… Balanced Classes: 65% low risk, 35% high riskâœ…å‡è¡¡ç±»åˆ«ï¼š65%ä½é£é™©ï¼Œ35%é«˜é£é™©
âœ… Validated: Random Forest accuracy 81.34%, ROC-AUC 0.87âœ…éªŒè¯ï¼šéšæœºæ£®æ—å‡†ç¡®ç‡81.34%,ROC-AUC 0.87


Quick Facts   å¿«é€Ÿçš„äº‹å®
Attribute   å±æ€§Value   ä»·å€¼Samples   æ ·å“2,169 patients   2169åæ‚£è€…Features   ç‰¹æ€§15 clinical features   15ä¸´åºŠç‰¹ç‚¹Target   ç›®æ ‡Binary (0=Low Risk, 1=High Risk)äºŒå…ƒï¼ˆ0=ä½é£é™©ï¼Œ1=é«˜é£é™©ï¼‰Data Source   æ•°æ®æºValley Medical Center, CAåŠ å·å±±è°·åŒ»ç–—ä¸­å¿ƒCollection Period   æ”¶é›†æœŸé—´Jan-Dec 2024Missing Data   ç¼ºå¤±çš„æ•°æ®0%Format   æ ¼å¼CSV, UTF-8   CSV, utf - 8Size   å¤§å°140 KB

Features Overview   åŠŸèƒ½æ¦‚è¿°
ğŸ“Š Demographics (3)   ğŸ“Šäººå£ç»Ÿè®¡(3)

Age: 40-95 years   å¹´é¾„ï¼š40-95å²
Gender: Female/Male   æ€§åˆ«:å¥³æ€§/ç”·æ€§
BMI: 18.5-44.2 kg/mÂ²   BMI: 18.5-44.2 kg/mÂ²ï¼›

ğŸ’“ Vital Signs (3)   ğŸ’“ç”Ÿå‘½ä½“å¾(3)

Systolic BP: 90-195.5 mmHgæ”¶ç¼©å‹ï¼š90-195.5 mmHg
Diastolic BP: 60-130 mmHgèˆ’å¼ å‹ï¼š60-130 mmHg
Heart Rate: 50-120 bpm   å¿ƒç‡ï¼šæ¯åˆ†é’Ÿ50-120æ¬¡

ğŸ«€ Cardiac Function (1)   ğŸ«€å¿ƒåŠŸèƒ½(1)

LVEF (Left Ventricular Ejection Fraction): 20-70% â­ Most Important Feature (31.5%)LVEFï¼ˆå·¦å¿ƒå®¤å°„è¡€åˆ†æ•°ï¼‰ï¼š20-70%â­

ğŸ§ª Biomarkers (4)   ğŸ§ªç”Ÿç‰©æ ‡å¿—ç‰©(4)

NT-proBNP: 50-8000 pg/mL â­ Second Most Important (10.3%)NT-proBNP: 50-8000 pg/mLâ­ç¬¬äºŒé‡è¦ï¼ˆ10.3%ï¼‰
Serum Creatinine: 0.5-2.5 mg/dLè¡€æ¸…è‚Œé…ï¼š0.5-2.5 mg/dL
Serum Sodium: 125-148 mEq/Lè¡€æ¸…é’ ï¼š125-148 mEq/L
Platelet Count: 100-450 Ã—10Â³/Î¼Lè¡€å°æ¿è®¡æ•°ï¼š100-450å€/ Î¼ L

ğŸ“‹ Medical History (4)   ğŸ“‹ç—…å²(4)

Diabetes: Yes/No (29% prevalence)ç³–å°¿ç—…ï¼šæ˜¯/å¦ï¼ˆæ‚£ç—…ç‡29%ï¼‰
Hypertension: Yes/No (45% prevalence)é«˜è¡€å‹ï¼šæ˜¯/å¦ï¼ˆ45%æ‚£ç—…ç‡ï¼‰
Anemia: Yes/No (25% prevalence)è´«è¡€ï¼šæ˜¯/å¦ï¼ˆ25%æ‚£ç—…ç‡ï¼‰
Smoking: Yes/No (35% prevalence)å¸çƒŸï¼šæ˜¯/å¦ï¼ˆæ‚£ç—…ç‡35%ï¼‰


What Makes This Dataset Special?è¿™ä¸ªæ•°æ®é›†çš„ç‰¹åˆ«ä¹‹å¤„æ˜¯ä»€ä¹ˆï¼Ÿ
ğŸ¥ Real-World Clinical DatağŸ¥çœŸå®ä¸–ç•Œä¸´åºŠæ•°æ®

Collected from actual hospital patients, not simulatedæ”¶é›†è‡ªçœŸå®çš„åŒ»é™¢ç—…äººï¼Œè€Œéæ¨¡æ‹Ÿ
Diverse patient population reflecting real community demographicså¤šæ ·åŒ–çš„æ‚£è€…ç¾¤ä½“åæ˜ äº†çœŸå®çš„ç¤¾åŒºäººå£ç»Ÿè®¡
Standard clinical practice measurements and protocolsæ ‡å‡†ä¸´åºŠå®è·µæµ‹é‡å’Œæ–¹æ¡ˆ

ğŸ“ˆ Excellent for ML   ğŸ“ˆéå¸¸é€‚åˆML

Perfect for Binary Classification: Balanced target variableå®Œç¾çš„äºŒå…ƒåˆ†ç±»ï¼šå¹³è¡¡çš„ç›®æ ‡å˜é‡
Feature Importance: Clear ranking from Random Forest analysisç‰¹å¾é‡è¦æ€§ï¼šä»éšæœºæ£®æ—åˆ†æä¸­æ˜ç¡®æ’å
Ready for SHAP Analysis: Interpretable features with clinical meaningå‡†å¤‡è¿›è¡ŒSHAPåˆ†æï¼šå…·æœ‰ä¸´åºŠæ„ä¹‰çš„å¯è§£é‡Šç‰¹å¾
Multiple Algorithm Support: Works well with XGBoost, LightGBM, Random Forest, Neural Networkså¤šç§ç®—æ³•æ”¯æŒï¼šä¸XGBoostï¼Œ LightGBMï¼Œéšæœºæ£®æ—ï¼Œç¥ç»ç½‘ç»œå·¥ä½œè‰¯å¥½

ğŸ”¬ Scientific Rigor   ğŸ”¬ç§‘å­¦ä¸¥è°¨æ€§

IRB Approved: Ethics approval (2024-VMC-HF-001)IRBæ‰¹å‡†ï¼šä¼¦ç†æ‰¹å‡†ï¼ˆ2024-VMC-HF-001ï¼‰
Quality Controlled: Dual independent data entry, 100% consistency checkè´¨é‡æ§åˆ¶ï¼šåŒé‡ç‹¬ç«‹æ•°æ®å½•å…¥ï¼Œ100%ä¸€è‡´æ€§æ£€æŸ¥
Standardized Measurements: International guideline-compliant protocolsæ ‡å‡†åŒ–æµ‹é‡ï¼šç¬¦åˆå›½é™…å‡†åˆ™çš„åè®®
Validated Reliability: Inter-rater ICC > 0.85ç»éªŒè¯çš„ä¿¡åº¦ï¼šinterrater ICC >ï¼› 0.85


Potential Use Cases   æ½œåœ¨ç”¨ä¾‹
ğŸ¤– Machine Learning   ğŸ¤–æœºå™¨å­¦ä¹ 

Binary classification model developmentäºŒå…ƒåˆ†ç±»æ¨¡å‹å¼€å‘
Ensemble learning experimentsé›†æˆå­¦ä¹ å®éªŒ
Feature selection studiesç‰¹å¾é€‰æ‹©ç ”ç©¶
Hyperparameter optimization benchmarksè¶…å‚æ•°ä¼˜åŒ–åŸºå‡†

ğŸ§  Explainable AI   ğŸ§ å¯è§£é‡Šçš„AI

SHAP value analysis   shapeå€¼åˆ†æ
LIME interpretability   çŸ³ç°å¯è§£é‡Šæ€§
Feature importance rankingç‰¹å¾é‡è¦æ€§æ’åº
Clinical decision rule extractionä¸´åºŠå†³ç­–è§„åˆ™æå–

ğŸ“ Educational   ğŸ“æ•™è‚²

Healthcare ML tutorials   åŒ»ç–—ä¿å¥MLæ•™ç¨‹
Medical data science coursesåŒ»å­¦æ•°æ®ç§‘å­¦è¯¾ç¨‹
Kaggle competition practiceKaggleæ¯”èµ›ç»ƒä¹ 
Student projects   å­¦ç”Ÿé¡¹ç›®

ğŸ¥ Clinical Research   ğŸ¥ä¸´åºŠç ”ç©¶

Risk stratification modelsé£é™©åˆ†å±‚æ¨¡å‹
Early warning systems   æ—©æœŸé¢„è­¦ç³»ç»Ÿ
Comparative algorithm studiesæ¯”è¾ƒç®—æ³•ç ”ç©¶
Biomarker validation   ç”Ÿç‰©æ ‡å¿—ç‰©çš„éªŒè¯
